Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 16, 2022; 10(29): 10428-10434
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10428
Prostate only radiotherapy using external beam radiotherapy: A clinician’s perspective
Jeong Won Lee, Mi Joo Chung
Jeong Won Lee, Department of Radiation Oncology, Daegu Catholic University School of Medicine, Daegu 42472, South Korea
Mi Joo Chung, Department of Radiation Oncology, Hanyang University Hanmaeum Changwon Hospital, Changwon 51139, South Korea
Author contributions: Lee JW performed the literatures search and drafted the manuscript; Chung MJ conceived the review and revised the manuscript; both authors have read and approved the manuscript.
Conflict-of-interest statement: All authors report no relevant conflict of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Corresponding author: Mi Joo Chung, MD, PhD, Assistant Professor, Doctor, Department of Radiation Oncology, Hanyang University Hanmaeum Changwon Hospital, No. 8 Yongdong-ro 57 beon-gil, Uichang-gu, Changwon 51139, South Korea.
Received: May 6, 2022
Peer-review started: May 6, 2022
First decision: August 4, 2022
Revised: August 12, 2022
Accepted: August 30, 2022
Article in press: August 30, 2022
Published online: October 16, 2022
Core Tip

Core Tip: The present study discussed the radiobiologic basis and external beam technical advancement of prostate-only radiotherapy (PORT) for localized prostate cancer from a clinician’s perspective. We verified the efficacy and safety of PORT by external beam radiotherapy, and radiotherapy techniques are developed to deliver higher doses of radiation to prostate safely. Therefore, PORT is recommended for localized prostate cancer patients, regardless of risk groups of patients.